Описание: This issue of Hematology/Oncology Clinics of North America is devoted to Neuroendocrine tumors. Articles in this issue include: Pathology Classification of Neuroendocrine Tumors; Clinical Presentation and Diagnosis of Neuroendocrine Tumors; Surgical Management of Gastrointestinal Carcinoid Tumors; Systemic Therapies for Advanced Gastrointestinal Carcinoid Tumors; Thymic and Bronchial Carcinoid Tumors; Surgical Management of Pancreatic Neuroendocrine Tumors; Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors; Pheochromocytoma and Paraganglioma; Poorly Differentiated Neuroendocrine Tumors; Role of Somatostatin Analogs in the Treatment of Neuroendocrine Tumors; Peptide Receptor Radiotherapy in the Treatment of Neuiroendocrine Tumors; Hepatic-Directed Therapies in Patients with Neuroendocrine Tumors; and Neuroendocrine Tumor Clinical Trial Interpretation and Design.
Описание: This book offers an overview of current treatments for patients with digestive neuroendocrine tumors (NETs). Covers a variety of treatments, from surgery to liver directed therapies to use of systemic chemotherapy and targeted agents to slow tumor progression.
Описание: Covers important advances in research surrounding the neuroendocrine control of metabolism. This title includes topics such as leptin signaling, hypothalmic inflammation, hypoglycemia awareness, perinatal programming of metabolic disease, substrates, and more.
Автор: Cardinali Daniel P., Pandi-Perumal S. R. Название: Neuroendocrine Correlates of Sleep/Wakefulness ISBN: 0387236414 ISBN-13(EAN): 9780387236414 Издательство: Springer Рейтинг: Цена: 24415 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: Deals with endocrine regulation of the behavioral state control. This title addresses a wide spectrum of sleep/wakefulness phenomena (both animals and humans), including pathogenesis, diagnosis, and management. It provides a summary of important issues in the neuroendocrine correlates of sleep/wakefulness.
Описание: The book describes the ability of a series of endocrine-derived compounds, i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to exert a direct anti-neoplastic activity or to potentiate the activity of traditional chemotherapeutic agents on neuroendocrine and solid tumors. In addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with important endocrine and extra-endcocrine action, is presented. Therefore, in addition to traditional chemotherapy, characterized by high toxicity and non-selective action on tumoral cells, the reader can find a new approach with more selective, less cytotoxic endocrine derived compounds
ООО "Логосфера " Тел:+7(495) 980-12-10 www.logobook.ru